Fred Welishe

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Protocol for the 3HP Options Trial: a hybrid type 3 implementation-effectiveness randomized trial of delivery strategies for short-course tuberculosis preventive therapy among people living with HIV in Uganda”.

Protocol for the 3HP Options Trial: a hybrid type 3 implementation-effectiveness randomized trial of delivery strategies for short-course tuberculosis preventive therapy among people living with HIV in Uganda

Implementation Science(2020)10.1186/s13012-020-01025-8

N/A

0.558DataRank · unranked

23 citations

Allan Musinguzi, Juliet Nabunje, Fred Welishe, Jackie Ssemata, Bishop Opira +16 more

Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trial

PLoS Medicine(2024)10.1371/journal.pmed.1004356

N/A

0.478DataRank · unranked

11 citations

Jillian L. Kadota, Allan Musinguzi, Fred Welishe, Anne Nakitende, Lydia Akello +20 more

Adverse Events Reported During Weekly Isoniazid-Rifapentine (3HP) Tuberculosis Preventive Treatment Among People With Human Immunodeficiency Virus in Uganda

Open Forum Infectious Diseases(2024)10.1093/ofid/ofae667

N/A

0.282DataRank · unranked

4 citations

Allan Musinguzi, Hélène E. Aschmann, Lydia Akello, Fred Welishe, Jane Nakimuli +8 more

Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda: A qualitative evaluation of the 3HP Options Trial

PLOS Global Public Health(2024)10.1371/journal.pgph.0003347

N/A

0.241DataRank · unranked

4 citations

Joan Ritar Kasidi, Jillian L. Kadota, Fred Welishe, Anne Nakitende, Lydia Akello +20 more

Preferences of people living with HIV for features of tuberculosis preventive treatment regimens – a discrete choice experiment

medRxiv(2023)10.1101/2023.09.13.23295043

N/A

0DataRank · unranked

1 citations

Allan Musinguzi, Jillian L. Kadota, Catherine Namale, Juliet Kakeeto, Jane Nakimuli +9 more

Acceptance and Completion of Rifapentine-based TB Preventive Therapy (3HP) Among People Living with HIV (PLHIV) in Kampala, Uganda – Patient and Health Worker Perspectives.

Research Square(2020)10.21203/rs.3.rs-92783/v1

N/A

0DataRank · unranked

0 citations

Allan Musinguzi, Jackie Ssemata, Fred Welishe, Juliet Nabunje, Jillian L. Kadota +8 more

Acceptance and completion of rifapentine-based TB preventive therapy (3HP) among people living with HIV (PLHIV) in Kampala, Uganda—patient and health worker perspectives

Implementation Science Communications(2021)10.1186/s43058-021-00173-2

N/A

0DataRank · unranked

22 citations

Allan Musinguzi, Jackie Ssemata, Fred Welishe, Juliet Nabunje, Jillian L. Kadota +8 more

Preferences of people living with HIV for features of tuberculosis preventive treatment regimens in Uganda: a discrete choice experiment

Journal of the International AIDS Society(2024)10.1002/jia2.26390

N/A

0DataRank · unranked

5 citations

Jillian L. Kadota, Catherine Namale, Juliet Kakeeto, Jane Nakimuli, Lydia Akello +8 more

Preference for daily (1HP) vs. weekly (3HP) isoniazid-rifapentine among people living with HIV in Uganda

IJTLD OPEN(2024)10.5588/ijtldopen.23.0283

N/A

0DataRank · unranked

4 citations

Hélène E. Aschmann, Jillian L. Kadota, Jane Nakimuli, Fred Welishe, Juliet Kakeeto +11 more